Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Muxan chloramine-T formulations for acute herpes labialis
2010-021144-17Phase 3Terminated
- Sponsor
- Engelhard Arzneimittel
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Tosylchloramide in herpes labialis (3 arms), sponsored by Engelhard Arzneimittel. Primary endpoint: Reduction of subjectively perceived symptoms. Started Oct 2010; status: terminated.
02
Drugs
Tosylchloramide
03
Conditions
herpes labialis
Beyond the preview
Go deeper on 2010-021144-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021144-17.